Senior Scientist, Oncology Research
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases.
See Yourself at Telix
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases.
The role of Sr. Scientist, Oncology Research is responsible for advancing preclinical research in radiopharmaceuticals for oncology. There will be an emphasis on developing combination therapies that leverage biological insights to achieve synergistic or additive therapeutic effects. The incumbent will oversee and manage research projects, collaborate with cross-functional and remote teams, and adapt to evolving data to inform experimental design and strategy. The position requires expertise in cancer biology or immunology and offers the opportunity to contribute to the development of next-generation therapeutic approaches in a rapidly evolving field.
Key Accountabilities
• Strategic Research Identification - Proactively identify and evaluate scientifically robust, high-impact research opportunities that integrate radiopharmaceuticals with standard-of-care modalities, including immunotherapy, to advance Telix's oncology pipeline.
• Collaborative Study - Design Partner with internal teams and external collaborators (academic institutions and industry partners) to design rigorous, hypothesis-driven preclinical studies that generate proof-of-concept and mechanism-of-action data for innovative combination therapies.
• Protocol Oversight and Development - Lead the drafting, review, and refinement of preclinical study protocols, ensuring scientific integrity, clarity, and alignment with project objectives.
• Data and Documentation Management - Ensure all preclinical study data, methodologies, and reports are accurately documented, up-to-date, and compliant with internal standards and regulatory expectations.
• Scientific Surveillance and Thought Leadership - Stay current with emerging literature and developments in radiopharmaceuticals, immunotherapy, tumor microenvironment biology, and related therapeutic areas to inform research strategy and maintain scientific leadership.
• Technical Expertise and Guidance - Provide expert technical input to internal stakeholders and external collaborators, contributing to experimental design, troubleshooting, and interpretation of complex biological data.
• Project Tracking and Milestone Management - Collaborate with project managers to monitor research progress, anticipate challenges, and ensure timely achievement of key milestones across concurrent projects.
• Due Diligence Support - Contribute to scientific due diligence efforts by evaluating potential collaborations and asset opportunities, providing insights into biological relevance, feasibility, and strategic fit.
Education and Experience
• Bachelor's degree plus eight (8) years' experience or Master's degree plus six (6) years' experience or PhD plus five (5) years' experience in preclinical oncology research.
• 4+ years of experience conducting experiments in syngeneic tumour models is required.
• Direct experience in the field of Immuno-Oncology / the Tumour Micro Environment is strongly preferred.
• Experience managing research studies with external partners (academic and/or CRO) is strongly preferred.
• Experience with radiopharmaceutical research is preferred.
• Experience studying the biology of tumour stroma is a plus.
• Working knowledge of various cellular immunological, gene expression, biomarker and in vitro / ex vivo assays is preferred (e.g. flow cytometry, IHC, qPCR, immune response monitoring).
At Telix, we believe everyone counts, we strive to be extraordinary, and we pursue our goals with determination and integrity. You will be part of an engaged and supportive group of colleagues who all have a shared purpose: to help people with cancer and rare diseases live longer, better quality lives. Being a Telix employee means being a part of a unique, global, interdisciplinary team working to deliver what's next in precision medicine. We have hybrid and remote employees located all around the world. We offer competitive salaries, annual performance-based bonuses, an equity-based incentive program, generous vacation, paid wellness days and support for learning and development.
Telix Pharmaceuticals is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, veteran status, and other legally protected characteristics.
VIEW OUR PRIVACY POLICY HERE
Apply Now
See Yourself at Telix
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases.
The role of Sr. Scientist, Oncology Research is responsible for advancing preclinical research in radiopharmaceuticals for oncology. There will be an emphasis on developing combination therapies that leverage biological insights to achieve synergistic or additive therapeutic effects. The incumbent will oversee and manage research projects, collaborate with cross-functional and remote teams, and adapt to evolving data to inform experimental design and strategy. The position requires expertise in cancer biology or immunology and offers the opportunity to contribute to the development of next-generation therapeutic approaches in a rapidly evolving field.
Key Accountabilities
• Strategic Research Identification - Proactively identify and evaluate scientifically robust, high-impact research opportunities that integrate radiopharmaceuticals with standard-of-care modalities, including immunotherapy, to advance Telix's oncology pipeline.
• Collaborative Study - Design Partner with internal teams and external collaborators (academic institutions and industry partners) to design rigorous, hypothesis-driven preclinical studies that generate proof-of-concept and mechanism-of-action data for innovative combination therapies.
• Protocol Oversight and Development - Lead the drafting, review, and refinement of preclinical study protocols, ensuring scientific integrity, clarity, and alignment with project objectives.
• Data and Documentation Management - Ensure all preclinical study data, methodologies, and reports are accurately documented, up-to-date, and compliant with internal standards and regulatory expectations.
• Scientific Surveillance and Thought Leadership - Stay current with emerging literature and developments in radiopharmaceuticals, immunotherapy, tumor microenvironment biology, and related therapeutic areas to inform research strategy and maintain scientific leadership.
• Technical Expertise and Guidance - Provide expert technical input to internal stakeholders and external collaborators, contributing to experimental design, troubleshooting, and interpretation of complex biological data.
• Project Tracking and Milestone Management - Collaborate with project managers to monitor research progress, anticipate challenges, and ensure timely achievement of key milestones across concurrent projects.
• Due Diligence Support - Contribute to scientific due diligence efforts by evaluating potential collaborations and asset opportunities, providing insights into biological relevance, feasibility, and strategic fit.
Education and Experience
• Bachelor's degree plus eight (8) years' experience or Master's degree plus six (6) years' experience or PhD plus five (5) years' experience in preclinical oncology research.
• 4+ years of experience conducting experiments in syngeneic tumour models is required.
• Direct experience in the field of Immuno-Oncology / the Tumour Micro Environment is strongly preferred.
• Experience managing research studies with external partners (academic and/or CRO) is strongly preferred.
• Experience with radiopharmaceutical research is preferred.
• Experience studying the biology of tumour stroma is a plus.
• Working knowledge of various cellular immunological, gene expression, biomarker and in vitro / ex vivo assays is preferred (e.g. flow cytometry, IHC, qPCR, immune response monitoring).
At Telix, we believe everyone counts, we strive to be extraordinary, and we pursue our goals with determination and integrity. You will be part of an engaged and supportive group of colleagues who all have a shared purpose: to help people with cancer and rare diseases live longer, better quality lives. Being a Telix employee means being a part of a unique, global, interdisciplinary team working to deliver what's next in precision medicine. We have hybrid and remote employees located all around the world. We offer competitive salaries, annual performance-based bonuses, an equity-based incentive program, generous vacation, paid wellness days and support for learning and development.
Telix Pharmaceuticals is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, veteran status, and other legally protected characteristics.
VIEW OUR PRIVACY POLICY HERE
Apply Now